Showing results (21-30 of 139) with videos related to

Sort By:
Pageof 14
Clinical and Experimental Rheumatology|August 9, 2021
Malignancies in spondyloarthritis with and without concomitant psoriasis, and the effect of disease modifying anti-rheumatic drugsHo Yin Chung, Shirley Chiu Wai Chan, Eva Tsz Fung Chui, et al.
ACS Infectious Diseases|November 11, 2022
Non-Neutralizing Epitopes Shade Neutralizing Epitopes against Omicron in a Multiple Epitope-Based VaccineHua-Rui Gong, Ye-Fan Hu, Xuechen Li, et al.
Cancer|October 15, 2008
A new prognostic score system in patients with advanced hepatocellular carcinoma not amendable to locoregional therapy: implication for patient selection in systemic therapy trialsThomas Yau, Tzy Jyun Yao, Pierre Chan, et al.
Postgraduate Medical Journal|April 17, 2023
Safety and tolerability of subcutaneous trastuzumab and intravenous pertuzumab as adjuvant treatment for HER2 positive breast cancer: a pilot studyChi Yan Wong, Roland Leung, Gin Wai Kwok, et al.
BMC Cancer|November 12, 2014
Lobular breast cancers lack the inverse relationship between ER/PR status and cell growth rate characteristic of ductal cancers in two independent patient cohorts: implications for tumor biology and adjuvant therapyHilda Wong, Silvia Lau, Polly Cheung, et al.
Liver Cancer|October 11, 2023
Predictive and Prognostic Potential of Liver Function Assessment in Patients with Advanced Hepatocellular Carcinoma: A Systematic Literature ReviewArndt Vogel, Robin K Kelley, Philip Johnson, et al.
Annals of Surgical Oncology|May 12, 2012
Is there a role for unstimulated thyroglobulin velocity in predicting recurrence in papillary thyroid carcinoma patients with detectable thyroglobulin after radioiodine ablation?Hilda Wong, Kai P Wong, Thomas Yau, et al.
IEEE/ACM Transactions on Computational Biology and Bioinformatics|September 4, 2023
Family-Specific Training Improves Linear B Cell Epitope Prediction for Emerging VirusesRan Liu, Ye-Fan Hu, Jin Du, et al.
Future Oncology (London, England)|June 4, 2020
Cabozantinib in combination with atezolizumab versus sorafenib in treatment-naive advanced hepatocellular carcinoma: COSMIC-312 Phase III study designRobin Kate Kelley, Jennifer W Oliver, Saswati Hazra, et al.
Cancer Chemotherapy and Pharmacology|June 16, 2007
A case of mixed adult Wilms' tumour and angiosarcoma responsive to carboplatin, etoposide and vincristine (CEO)Thomas Yau, C H Leong, W K Chan, et al.
Pageof 14